• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Model Number S-60-150-120-P6
Device Problems Difficult to Remove (1528); Improper or Incorrect Procedure or Method (2017); Mechanical Jam (2983); Activation Failure (3270)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/15/2022
Event Type  malfunction  
Event Description
It was reported that the procedure was to treat a mildly tortuous, heavily calcified superficial femoral artery that was 100% stenosed.The procedure was performed via contralateral approach with a non-abbot 5f sheath.Per the physician as there was a previously implanted stent in the common femoral artery, a smaller diameter sheath (5f) was thought as best to use as much as possible for this procedure.After a 0.014 gw crossed, pre-dilatation was performed with a 6x150mm non-abbott balloon.Then a 6x150mm supera was advanced to the lesion and deployment initiated, however, the deployment lock was not unlocked.Approximately 2cm of the stent was deployed, but the thumbslide became unable to be pushed.Therefore, stent deployment did not proceed any further.The delivery system was removed as a single unit.Then the sheath was replaced with 6f sheath and after the gw crossed, a non-abbott stent was deployed to successfully complete the procedure.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
(b)(4).The device is expected to be returned for evaluation.It has not yet been received.A follow up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was to treat a mildly tortuous, heavily calcified superficial femoral artery that was 100% stenosed.The procedure was performed via contralateral approach with a non-abbot 5f sheath.Per the physician as there was a previously implanted stent in the common femoral artery, a smaller diameter sheath (5f) was thought as best to use as much as possible for this procedure.After a 0.014 gw crossed, pre-dilatation was performed with a 6x150mm non-abbott balloon.Then a 6x150mm supera was advanced to the lesion and deployment initiated, however, the deployment lock was not unlocked.Approximately 2cm of the stent was deployed, but the thumbslide became unable to be pushed.Therefore, stent deployment did not proceed any further.The delivery system was removed as a single unit.Then the sheath was replaced with 6f sheath and after the gw crossed, a non-abbott stent was deployed to successfully complete the procedure.There were no adverse patient effects and no clinically significant delay in the procedure.Subsequent to the initially filed mdr report, the account provided additional information: during removal of the supera device, resistance was met with the non-abbott sheath.Additional information received by the account confirms that the physician never reached the step of unlocking the deployment lock as the thumbslide would not slide at all from the start.No additional information was provided.
 
Manufacturer Narrative
The device was returned for analysis.The reported activation/deployment failure, the reported mechanical jam and the reported difficult to remove were unable to be replicated in a testing environment due to the condition of the returned device.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot specific quality issue.Reportedly, the procedure was performed with a non-abbot 5f sheath.It should be noted that the supera peripheral stent system instructions for use states the minimum sheath compatibility is 6f.The deviation of the ifu likely caused/contributed to the reported difficult to remove.As there was no reported damage noted to the device during the inspection prior to use, the investigation determined the reported difficulties appear to be related to circumstances of the procedure and subsequent deviation of the instructions for use as it is likely that interactions with the mildly tortuous, heavily calcified and 100% stenosed anatomy resulted in the ratchet being unable to properly engage and release the stent from the delivery system; thus resulting in reported activation/ deployment failure and the reported mechanical jam.During removal interaction with the undersized sheath resulted in the reported difficult to remove.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.H6 medical device problem code 2017- failure to follow steps / instructions was removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key15382595
MDR Text Key301020605
Report Number2024168-2022-09501
Device Sequence Number1
Product Code NIP
UDI-Device Identifier08717648211843
UDI-Public08717648211843
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/08/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2023
Device Model NumberS-60-150-120-P6
Device Catalogue NumberS-60-150-120-P6
Device Lot Number1091061
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/11/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/10/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
PARENT SELECT 5F (MEDIKIT); SHIDEN 6*150 MM
-
-